Physician

James Leon Khatcheressian, M.D.

According to 2025 Medicare claims, James Khatcheressian, M.D. (NPI: 1366536674) practices medical oncology in the Richmond, VA market, with the plurality of this provider's patient population coming from Henrico, VA. This provider's primary affiliated billing organization is VIRGINIA CANCER INSTITUTE INCORPORATED (NPI: 1730130980; TIN: 54-1066435) and primary practice location at 23229-8605.

Khatcheressian's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 932 traditional Medicare patients, billed 107,015 HCPCS/CPT codes, and received $2,435,753 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 2,133 prescription claims across 345 beneficiaries totaling $4,151,969 in drug costs, led by Ibrance (Palbociclib). DME data shows 43 claims. Open Payments data shows 15 records totaling $10,244. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $386,507 to $4,151,969. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,141	151,500	$2,288,480
2016	1,161	170,263	$2,769,258
2017	1,176	151,855	$2,647,942
2018	1,126	122,185	$1,939,976
2019	1,221	166,767	$2,978,491
2020	1,063	125,883	$2,601,599
2021	1,095	135,773	$2,524,723
2022	1,147	159,891	$2,848,397
2023	933	124,414	$2,114,447
2024	932	107,015	$2,435,753

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	338	2,024	$386,507
2016	354	2,229	$832,654
2017	362	2,314	$1,072,528
2018	394	2,580	$1,275,862
2019	421	2,718	$1,902,764
2020	405	2,749	$2,166,842
2021	412	2,480	$1,587,510
2022	382	2,213	$1,640,074
2023	373	2,011	$1,795,597
2024	345	2,133	$4,151,969

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	11	201	$37,218
2016	N/R	134	$6,307
2017	N/R	N/R	N/R
2018	N/R	106	$15,935
2019	N/R	35	$2,516
2020	N/R	22	$2,028
2021	N/R	N/R	N/R
2022	N/R	62	$1,993
2023	N/R	N/R	N/R
2024	N/R	43	$2,885

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	161	358	$133
96413	Administration of chemotherapy into vein, 1 hour or less	110	272	$96
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	434	586	$90
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	236	288	$12
96372	Injection of drug or substance under skin or into muscle	154	350	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ibrance	Palbociclib	52	1,456	$813,391
Brukinsa	Zanubrutinib	53	1,590	$740,318
Calquence	Acalabrutinib Maleate	22	660	$329,243
Kisqali	Ribociclib Succinate	20	560	$310,334
Revlimid	Lenalidomide	24	588	$304,123

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
L8000	Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type	N	N/R	11	$1,446
E0656	Segmental pneumatic appliance for use with pneumatic compressor, trunk	Y	N/R	16	$742
E0657	Segmental pneumatic appliance for use with pneumatic compressor, chest	Y	N/R	16	$697

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	12	$239	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	3	$10,004	Genentech, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for James Leon Khatcheressian, M.D.?

Tedicare shows public-source Medicare data for James Leon Khatcheressian, M.D. (NPI 1366536674), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James Leon Khatcheressian, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to James Leon Khatcheressian, M.D.?

James Leon Khatcheressian, M.D. is linked to VIRGINIA CANCER INSTITUTE INCORPORATED (billing NPI 1730130980) in the available physician profile data.

Does James Leon Khatcheressian, M.D. have Open Payments data?

James Leon Khatcheressian, M.D. has 15 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.